U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 1-7, 2020
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: March 1-7, 2020

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

No Significant Event

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

No Significant Event

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/02/2020
Location: San Francisco, CA
Subject: 27th International Molecular Med TRI-CON: Advancing Precision Medicine: C10: Renaissance of Gene Therapy and Genome Editing
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from industry, academia, government, and media

Event Date: 03/03/2020
Location: Silver Spring, MD
Subject: Facilitating End-to-End Development of Individualized Therapeutics Public Workshop
FDA Participant/Group: CELIA SILVERMAN; LARISSA LAPTEVA; SANDHYA SANDUJA; REBECCA REINDEL; JULIENNE VAILLANCOURT; ROBERT SCHOOLEY; ZHENZHEN XU; ZUBEN SAUNA; GOPA RAYCHAUDHURI;
Non FDA Participant/Group: Representatives from government, academia, industry

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 03/04/2020
Location: Silver Spring, MD
Subject: Opening Remarks (Remotely): Colorado BioScience Association Medical Device Symposium
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from various industry groups

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

Event Date: 03/05/2020
Location: Silver Spring, MD
Subject: Zofran Citizen Petition
FDA Participant/Group: MEADOW PLATT; ELIZABETH JUNGMAN; JANICE WEINER; NICHOLAS BESHARA; KAREN SCHIFTER; AMANDA EDMONDS; ANNAMARIE KEMPIC; SARA BEARDSLEY;
Non FDA Participant/Group: Brennan Torregrossa, Bridget Lankford , Patrick Wier, Sabine Luik (Glaxo Smith Kline); Jennifer Hill (Shook, Hardy & Bacon LLP); Amy Saharia (Williams & Connolly LLP); Thomas Sheehan (Phillips Lytle LLP);